| 35.76 Data as of May 17 |  0.00 / 0.00%Today’s Change | 20.04 Today|||52-Week Range 37.40 | +49.19% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $2.0B |
Company Description
The Medicines Co. is a pharmaceutical company focuses on advancing the treatment of critical care patients through the delivery of medicines to the worldwide hospital marketplace. The company has three marketed products, Angiomax, Cleviprex injectable emulsion and its ready-to-use formulation of Argatroban. Its also have a pipeline of acute and intensive care hospital products in development, including three late-stage development product candidates, cangrelor, oritavancin and MDCO-157, and two early stage development product candidates, MDCO-2010 and MDCO-216. Medicines was founded by Clive A. Meanwell and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.
Employees
Shareholders
| Mutual fund holders | 55.65% |
| Other institutional | 49.14% |
| Individual stakeholders | 11.64% |
Top Executives
| Clive A. Meanwell, MD, PhD | Chairman & Chief Executive Officer |
| Glenn P. Sblendorio, MBA | President, CFO, Treasurer & Director |
| Helmut Giersiefen, PhD | Chief Information & Knowledge Officer |
| Paul Michael Antinori | Secretary, Senior Vice President & General Counsel |
| Brent Furse | Chief Customer Officer & Senior Vice President |
.
